Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Molecular imaging using PET-CT and personalised therapy with neuroendocrine tumours

NCRI 2013

Published: 12 Nov 2013

Views: 4390

Rating:

Save

Dr Harshad Kulkarni - Zentralklinik, Bad Berka, Germany

Dr Harshad Kulkarni talks to ecancer at the 2013 NCRI Cancer Conference in Liverpool about PET/CT on neuroendocrine tumours.

A German multi-institutional registry study found that this is an effective therapy for patients with G1-2 neuroendocrine tumours with a survival advantage of several years compared to other therapies and only minor side effects.

The concept of theranostics has now been translated to other malignancies such as prostate cancer.

Related Videos

Rationale for routine use of IORT for early breast cancer and data for specific...

Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany

Rationale for routine use of IORT for early breast cancer and data for specific indications ( Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany )

Breast and emerging indications for IORT

Dr David Martinez Perez - AUNA, Lima, Peru

Breast and emerging indications for IORT ( Dr David Martinez Perez - AUNA, Lima, Peru )

The advantages of IORT for early breast cancer treatment

Dr David Martinez Perez - AUNA, Lima, Peru

The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )

The pros and cons of breast IORT and ultra hypofractionation (FR)

Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France

$The pros and cons of breast IORT and ultra hypofractionation (FR) ( Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France )$

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy...

Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC ( Dr Renu Eapen - Peter MacCallum Cancer Centre, Melbourne, Australia )

Rationale for routine use of IORT for early breast cancer and data for specific...

Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany

Rationale for routine use of IORT for early breast cancer and data for specific indications ( Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany )

Single-dose IORT during lumpectomy for breast cancer an innovative patient...

Dr Jayant Vaidya - University College London, London, UK

Single-dose IORT during lumpectomy for breast cancer an innovative patient-centred treatment ( Dr Jayant Vaidya - University College London, London, UK )

Global adoption of single-shot targeted IORT for breast cancer

Dr Jayant Vaidya - University College London, London, UK

Global adoption of single-shot targeted IORT for breast cancer ( Dr Jayant Vaidya - University College London, London, UK )

The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation...

Dr Jayant Vaidya - University College London, London, UK

The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival ( Dr Jayant Vaidya - University College London, London, UK )

More from ecancer